Abstract
To evaluate real world adherence, persistence, relapse, physical disability, and neurological impairment among patients with multiple sclerosis (MS) treated with oral disease-modifying therapies (DMTs).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
